Evidence map›Paper›PMID 17673808›Full record

ReviewMedical oncology (Northwood, London, England)2007

Recent advances in the diagnosis and therapy of Richter's syndrome.

Ronan Swords, John Bruzzi, Francis Giles

Abstract readReview
PubMed Publisher
In one paragraph

Review in Medical oncology (Northwood, London, England), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 34 citations in OpenAlex.

  1. [Clinical value of PET/CT in the diagnosis of Richter syndrome].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2020
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Richter transformation with c-MYC overexpression: report of three cases.International journal of clinical and experimental pathology · 2015
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Ronan SwordsDepartment of Haematology, University College Hospital Galway, Galway, Ireland.
John Bruzzi
Francis Giles
The University of Texas MD Anderson Cancer Center · USUniversity Hospital Galway · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Richter's syndrome (RS) denotes the development of aggressive lymphoma that arises in patients with chronic lymphocytic leukemia (CLL). Presenting features typically include a rapid clinical deterioration with fever in the absence of infection, progressive lymph node enlargement, and an elevation in serum LDH. Diagnostic biopsy of affected sites usually reveals large cell lymphomas; however, Hodgkin variant cases have been described. Richter's transformation occurs in approx 5% of CLL patients and may be associated with infection with Epstein-Barr virus (EBV). Chromosome 11 and 14 abnormalities have also been described as well as tumor suppressor gene defects involving p53, p21, and p27. Treatment options for these patients are limited and include combination chemotherapy with or without the addition of monoclonal antibodies and stem cell transplantation. Response to therapy is variable and generally short-lived. Median survival is usually in the order of 5-8 mo. More effective management for RS is needed as well as prognostic models that will identify CLL patients at risk of transformation. This review will address the current status of RS and deal with the pathophysiology, diagnostic approach, and treatment of this challenging disease.

Indexed as

Antineoplastic AgentsCell Transformation, NeoplasticCitratesFluorodeoxyglucose F18GalliumGallium RadioisotopesHumansLeukemia, Lymphocytic, Chronic, B-CellLymphoma, B-CellPositron-Emission TomographyRadiopharmaceuticalsSyndromeAntineoplastic AgentsCitratesFluorodeoxyglucose F18Galliumgallium citrateGallium RadioisotopesRadiopharmaceuticals

Identifiers

PMID17673808
OpenAlexW2077157566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.